Ashwin Kishtagari, MD, of Vanderbilt University Medical Center in Nashville, summarizes 7 studies presented at the EHA 2025 Congress.

Even before recent layoffs, the FDA’s investigative force struggled to monitor drug-making factories in India and China.

US patients with metastatic urothelial cancer have seen improvements in survival since ICIs and ADCs have entered the market, data suggest.

Amid the growing popularity of cannabis, it is perhaps not surprising that clinicians are increasingly accepting its use among cancer survivors,” the researchers wrote.

COVID-19 cases are on the rise again across the United States, according to data from the US Centers for Disease Control and Prevention.

The investigative unit, which looks into potential safety issues with drugs, vaccines, medical devices, and other products, has had a retention problem for years. Inspectors leave so often that, even ...

Cancer patients without health insurance have not derived the same benefits from the introduction of ICIs as patients with private insurance.

The findings of this case series study show substantial variation in the choice of the TNT regimen and were overall aligned with those reported in clinical trials, suggesting the efficacy of TNT in a ...

Adolescents with cancer and their parents said parents should have access to non-sensitive information in patient portals.

The FDA has accepted the supplemental new drug application for decitabine/cedazuridine plus venetoclax to treat adults with AML.

When researchers used a gene therapy to restore blood vessel health by counteracting the effects of Activin-A, they were able to prevent muscle loss.

HHS Secretary Robert F. Kennedy Jr. abruptly postponed a meeting of the USPSTF, raising concerns that he will be reshaping the task force.